- £669.89m
- £775.65m
- £278.81m
- 54
- 21
- 67
- 42
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 144 | 199 | 218 | 242 | 279 |
Cost of Revenue | |||||
Gross Profit | 107 | 144 | 153 | 172 | 198 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 128 | 176 | 182 | 219 | 391 |
Operating Profit | 15.4 | 22.8 | 35.5 | 23.4 | -112 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 14.7 | 20.6 | 34.3 | 21.7 | -119 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.2 | 17.1 | 26.9 | 15.3 | -120 |
Net Income Before Extraordinary Items | |||||
Net Income | 12.2 | 17.1 | 26.9 | 15.3 | -120 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12.2 | 17.1 | 26.9 | 15.3 | -120 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.101 | 0.1 | 0.129 | 0.096 | 0.033 |
Dividends per Share |